Innospec Inc. (NASDAQ:IOSP) SVP Hardy Louis Griffin III Sells 161 Shares

Innospec Inc. (NASDAQ:IOSP - Get Free Report) SVP Hardy Louis Griffin III sold 161 shares of the company's stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $117.52, for a total transaction of $18,920.72. Following the completion of the sale, the senior vice president now directly owns 4,523 shares of the company's stock, valued at $531,542.96. The trade was a 3.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Innospec Trading Down 1.7 %

Shares of IOSP stock traded down $1.92 during trading hours on Monday, hitting $111.43. 115,040 shares of the company were exchanged, compared to its average volume of 112,440. Innospec Inc. has a 52-week low of $103.65 and a 52-week high of $133.71. The firm has a fifty day simple moving average of $113.15 and a 200 day simple moving average of $113.99. The stock has a market capitalization of $2.78 billion, a price-to-earnings ratio of 19.45 and a beta of 1.09.

Innospec (NASDAQ:IOSP - Get Free Report) last issued its earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share for the quarter, hitting analysts' consensus estimates of $1.35. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The firm had revenue of $443.40 million during the quarter, compared to analyst estimates of $442.13 million. During the same quarter last year, the business earned $1.59 earnings per share. The company's quarterly revenue was down 4.5% on a year-over-year basis. Sell-side analysts anticipate that Innospec Inc. will post 5.87 EPS for the current year.

Institutional Investors Weigh In On Innospec

Several institutional investors have recently made changes to their positions in IOSP. US Bancorp DE grew its stake in Innospec by 323.6% during the third quarter. US Bancorp DE now owns 5,490 shares of the specialty chemicals company's stock valued at $621,000 after acquiring an additional 4,194 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Innospec by 3.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 336,522 shares of the specialty chemicals company's stock worth $38,057,000 after purchasing an additional 11,479 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Innospec by 24.6% in the third quarter. JPMorgan Chase & Co. now owns 266,688 shares of the specialty chemicals company's stock valued at $30,160,000 after purchasing an additional 52,640 shares in the last quarter. HighTower Advisors LLC lifted its position in Innospec by 5.2% during the third quarter. HighTower Advisors LLC now owns 3,103 shares of the specialty chemicals company's stock valued at $350,000 after purchasing an additional 154 shares during the last quarter. Finally, Citigroup Inc. grew its stake in Innospec by 46.1% in the 3rd quarter. Citigroup Inc. now owns 32,193 shares of the specialty chemicals company's stock worth $3,641,000 after buying an additional 10,162 shares in the last quarter. Hedge funds and other institutional investors own 96.64% of the company's stock.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Innospec from a "strong-buy" rating to a "buy" rating in a research report on Saturday, January 11th.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.